Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Aveo, Astellas report superiority of Tivozanib in renal cell cancer trial - Pharmaceutical Business Review |
 |
 |
|
Pharmaceutical Business Review Aveo Pharmaceuticals and Astellas Pharma have announced that superiority results of tivozanib over sorafenib from TIVO-1, a global, randomized Phase 3 clinical trial, in patients with advanced renal cell carcinoma (RCC). Tivozanib is a potent, ... Renal Cell Carcinoma Drug Gets Positive Results ThirdAge AVEO and Astellas Announce Tivozanib Successfully Demonstrated Progression |
